CAS 99-73-0|2,4′-dibromoacetophenone
| Common Name | 2,4′-dibromoacetophenone | ||
|---|---|---|---|
| CAS Number | 99-73-0 | Molecular Weight | 277.941 |
| Density | 1.8±0.1 g/cm3 | Boiling Point | 310.4±22.0 °C at 760 mmHg |
| Molecular Formula | C8H6Br2O | Melting Point | 108-110 °C(lit.) |
| MSDS | ChineseUSA | Flash Point | 114.1±8.9 °C |
| Symbol | GHS05 | Signal Word | Danger |
Names
| Name | 2,4'-Dibromoacetophenone |
|---|---|
| Synonym | More Synonyms |
Chemical & Physical Properties
| Density | 1.8±0.1 g/cm3 |
|---|---|
| Boiling Point | 310.4±22.0 °C at 760 mmHg |
| Melting Point | 108-110 °C(lit.) |
| Molecular Formula | C8H6Br2O |
| Molecular Weight | 277.941 |
| Flash Point | 114.1±8.9 °C |
| Exact Mass | 275.878540 |
| PSA | 17.07000 |
| LogP | 2.95 |
| Vapour Pressure | 0.0±0.7 mmHg at 25°C |
| Index of Refraction | 1.604 |
| InChIKey | FKJSFKCZZIXQIP-UHFFFAOYSA-N |
| SMILES | O=C(CBr)c1ccc(Br)cc1 |
| Stability | Stable. Incompatible with strong bases, strong reducing agents, strong oxidizing agents. |
Toxicological Information
CHEMICAL IDENTIFICATION |
ACUTE TOXICITY DATA - TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- >2 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- MEXPAG Medicina Experimentalis. (Basel, Switzerland) V.1-11, 1959-64; V.18-19, 1968-69. For publisher information, see JNMDBO. Volume(issue)/page/year: 11,137,1964
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 18 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- CSLNX* U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. (Aberdeen Proving Ground, MD 21010) Volume(issue)/page/year: NX#02407 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X5162 No. of Facilities: 7 (estimated) No. of Industries: 1 No. of Occupations: 1 No. of Employees: 28 (estimated)
Safety Information
| Symbol | GHS05 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H314 |
| Precautionary Statements | P280-P305 + P351 + P338-P310 |
| Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| Hazard Codes | C:Corrosive; |
| Risk Phrases | R34 |
| Safety Phrases | S26-S36/37/39-S45 |
| RIDADR | UN 3261 8/PG 2 |
| WGK Germany | 2 |
| RTECS | AM6950000 |
| Packaging Group | III |
| Hazard Class | 8 |
| HS Code | 29147090 |
Customs
| HS Code | 2914700090 |
|---|---|
| Summary | HS: 2914700090 halogenated, sulphonated, nitrated or nitrosated derivatives of ketones and quinones, whether or not with other oxygen function Tax rebate rate:9.0% Supervision conditions:none VAT:17.0% MFN tariff:5.5% General tariff:30.0% |
Articles39
More Articles| Switching reversibility to irreversibility in glycogen synthase kinase 3 inhibitors: clues for specific design of new compounds. J. Med. Chem. 54 , 4042-56, (2011) Development of kinase-targeted therapies for central nervous system (CNS) diseases is a great challenge. Glycogen synthase kinase 3 (GSK-3) offers a great potential for severe CNS unmet diseases, bein... | |
| Identification and characterisation of novel inhibitors on extrinsic tenase complex from Bungarus fasciatus (banded krait) venom. Thromb. Haemost. 112(4) , 700-15, (2014) Snake venoms are excellent sources of pharmacologically active proteins and peptides, and hence are potential sources of leads for drug developments. It has been previously established that krait (Bun... | |
| Effects of vipoxin and its components on HepG2 cells. Toxicon 94 , 36-44, (2015) Snake venom Phospholipases A2 (svPLA2) are among the main toxic venom components with a great impact on different tissues and organs based on their catalytic specificity and a variety of pharmacologic... |
Synonyms
| 2-Bromo-1-(4-bromophenyl)ethanone |
| BromophenacylBromide |
| PBPB |
| 2,4'-Dibromoacetophenone |
| p-Bromophenacyl bromide |
| 2-bromo-1-(4-bromophenyl)-1-ethanone |
| Ethanone, 2-bromo-1- (4-bromophenyl)- |
| 2-bromo-4'-bromoacetophenone |
| 2,4`-Dibromoacetophenone |
| 2,4'-Dibromo-acetophenone |
| α,p-Dibromoacetophenone |
| Ethanone, 2-bromo-1-(4-bromophenyl)- |
| 2,3-DIFLUOROBENZOTRIFLUORIDE |
| 2,4′-dibromoacetophenone |
| MFCD00000200 |
| p-α-Dibromoacetophenone |
| 2-bromo-1-(4-bromophenyl)ethan-1-one |
| EINECS 202-783-6 |
| p-bromophenacyl-8 |
